ITM Isotope Technologies Munich and Canadian Nuclear Laboratories have launched a company called Actineer to focus on the production of actinium-225 (Ac-225).
Ac-225 is a radioisotope used in the treatment of cancer. Under terms of the deal, Actineer will establish short-term production capabilities of the isotope based on current infrastructure, with plans being made for the construction of a new production facility.
The joint venture remains subject to further closing conditions expected to be satisfied in early 2024, ITM noted. Canadian Nuclear Labs manages and operates a national laboratory at Chalk River, Ontario, on behalf of Atomic Energy of Canada Limited.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
